Monotherapy or combination therapy for hospitalized patients with community-acquired pneumonia: not yet the end of the story?
- PMID: 18419483
- DOI: 10.1086/587666
Monotherapy or combination therapy for hospitalized patients with community-acquired pneumonia: not yet the end of the story?
Comment on
-
Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial.Clin Infect Dis. 2008 May 15;46(10):1499-509. doi: 10.1086/587519. Clin Infect Dis. 2008. PMID: 18419482 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical